It has been previously shown that recombinant fd phages, expressing a CD8 epitope and directed to CD205+ DCs (fdsc-αDEC), are potent inducers of Ag-specific CTL responses and are more effective than other immunization strategies for inhibiting the growth of the B16 tumor in vivo (1), reviewed in Ref. The gene discussed is CD8A; the disease is neoplasm.